Your browser is no longer supported. Please, upgrade your browser.
Settings
MGTX MeiraGTx Holdings plc daily Stock Chart
MGTX [NASD]
MeiraGTx Holdings plc
Index- P/E- EPS (ttm)-1.57 Insider Own7.90% Shs Outstand36.97M Perf Week-4.29%
Market Cap465.19M Forward P/E- EPS next Y-3.18 Insider Trans-3.53% Shs Float21.46M Perf Month1.81%
Income-57.00M PEG- EPS next Q-0.75 Inst Own58.30% Short Float1.82% Perf Quarter-11.13%
Sales17.20M P/S27.05 EPS this Y63.10% Inst Trans0.70% Short Ratio3.95 Perf Half Y-4.78%
Book/sh4.67 P/B2.77 EPS next Y-17.80% ROA-18.40% Target Price- Perf Year-11.43%
Cash/sh5.42 P/C2.39 EPS next 5Y2.40% ROE-30.70% 52W Range8.82 - 22.32 Perf YTD-35.36%
Dividend- P/FCF- EPS past 5Y- ROI-30.50% 52W High-42.03% Beta-
Dividend %- Quick Ratio5.00 Sales past 5Y- Gross Margin- 52W Low46.71% ATR0.79
Employees168 Current Ratio5.00 Sales Q/Q25.00% Oper. Margin- RSI (14)44.35 Volatility6.25% 5.60%
OptionableYes Debt/Eq0.00 EPS Q/Q-8.40% Profit Margin- Rel Volume0.36 Prev Close12.92
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume98.90K Price12.94
Recom1.80 SMA20-3.20% SMA50-3.22% SMA200-10.98% Volume36,339 Change0.15%
Sep-15-20Resumed BofA Securities Buy $20
Sep-03-19Initiated Piper Jaffray Overweight $40
Feb-27-19Reiterated Chardan Capital Markets Buy $30 → $40
Jul-03-18Initiated BofA/Merrill Buy
Jul-03-18Initiated Barclays Overweight
Oct-14-20 10:25AM  
Oct-07-20 06:10AM  
Oct-03-20 10:50AM  
Sep-28-20 04:30PM  
Sep-22-20 08:30AM  
Sep-15-20 08:39AM  
Aug-12-20 09:42AM  
Aug-06-20 08:00AM  
Aug-05-20 08:30AM  
Jul-27-20 08:18AM  
Jul-17-20 08:45AM  
07:30AM  
Jun-26-20 12:00PM  
Jun-23-20 11:07PM  
May-26-20 08:30AM  
May-07-20 04:30PM  
May-06-20 04:30PM  
Mar-18-20 09:10AM  
Mar-11-20 05:00PM  
Mar-02-20 08:30AM  
Feb-24-20 04:30PM  
Feb-11-20 07:37AM  
Dec-24-19 12:00PM  
Dec-16-19 09:34AM  
Dec-13-19 03:07PM  
Dec-05-19 04:30PM  
03:49AM  
Dec-04-19 09:42AM  
Nov-26-19 04:30PM  
Nov-13-19 09:13AM  
Nov-07-19 08:00AM  
Oct-28-19 04:13PM  
Oct-03-19 04:45PM  
04:45PM  
Sep-10-19 08:30AM  
Aug-23-19 09:00PM  
Aug-15-19 12:17PM  
Aug-08-19 06:50AM  
Aug-07-19 04:12PM  
08:00AM  
Jul-05-19 04:33PM  
Jul-01-19 08:19AM  
Jun-28-19 08:35PM  
Jun-14-19 11:15AM  
May-19-19 09:00AM  
May-17-19 05:30PM  
May-14-19 08:00AM  
07:30AM  
May-10-19 08:30AM  
May-06-19 04:30PM  
Apr-25-19 04:30PM  
09:27AM  
Apr-24-19 09:11AM  
Mar-26-19 04:05PM  
Mar-11-19 12:24PM  
Mar-10-19 10:36AM  
Mar-06-19 04:30PM  
Mar-04-19 11:36AM  
Feb-27-19 08:15AM  
Feb-21-19 04:30PM  
Feb-05-19 08:30AM  
Jan-31-19 06:30AM  
06:30AM  
Jan-04-19 02:22PM  
Jan-02-19 08:30AM  
Dec-12-18 08:30AM  
Nov-08-18 08:30AM  
Oct-31-18 08:30AM  
Oct-25-18 08:30AM  
Oct-16-18 08:00AM  
Oct-09-18 07:00AM  
Oct-02-18 04:30PM  
Aug-27-18 08:47AM  
08:00AM  
Aug-20-18 08:00AM  
Aug-13-18 07:00AM  
Aug-08-18 08:00AM  
Jun-30-18 12:01AM  
Jun-26-18 08:00AM  
Jun-21-18 08:00AM  
Jun-12-18 05:44PM  
MeiraGTx Holdings plc, a clinical-stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; neurodegenerative diseases, such as amyothrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. The company was founded in 2015 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Naylor StuartChief Development OfficerOct 05Sale15.003014,515463,662Oct 07 04:55 PM
MARCUS JOEL SDirectorAug 12Sale14.157,959112,6200Aug 12 05:49 PM
MARCUS JOEL SDirectorAug 11Sale13.867,500103,9507,959Aug 12 05:49 PM
MARCUS JOEL SDirectorAug 10Option Exercise5.6315,45987,03415,459Aug 12 05:49 PM
Naylor StuartChief Development OfficerJul 21Sale15.047,698115,778463,963Jul 22 05:37 PM
Naylor StuartChief Development OfficerJul 20Sale15.002,35635,340471,661Jul 22 05:37 PM
SHENK THOMAS EDirectorJul 20Sale15.006,667100,005157,476Jul 22 05:39 PM
Forbes AlexandriaPresident & CEOMay 22Sale15.189,125138,5181,418,081May 22 05:34 PM
Forbes AlexandriaPresident & CEOMay 21Sale15.1814,732223,6321,427,206May 22 05:34 PM
Giroux RichardCFO & COOMay 21Sale15.1611,786178,6761,064,518May 22 05:44 PM
Giroux RichardCFO & COOMay 20Sale15.036,14392,3291,076,304May 22 05:44 PM
Forbes AlexandriaPresident & CEOMay 20Sale15.046,14392,3911,441,938May 22 05:34 PM
Giroux RichardCFO & COOMay 13Sale15.38711,0921,082,447May 15 05:10 PM
MARCUS JOEL SDirectorMay 12Sale15.774,92277,62175,000May 14 05:25 PM
Naylor StuartChief Development OfficerMay 11Sale15.3911,304173,969474,017May 13 05:36 PM
SHENK THOMAS EDirectorMay 11Sale15.002,18432,760164,143May 13 05:37 PM
Naylor StuartChief Development OfficerApr 20Sale15.0069610,440485,321Apr 22 05:02 PM
SHENK THOMAS EDirectorApr 20Sale15.004,48267,230166,327Apr 22 05:00 PM
Naylor StuartChief Development OfficerFeb 19Sale17.606,000105,600486,017Feb 20 05:28 PM
Naylor StuartChief Development OfficerFeb 18Sale18.326,000109,912492,017Feb 20 05:28 PM
Forbes AlexandriaPresident & CEOJan 29Sale17.7715,000266,5501,448,081Jan 30 05:30 PM
Forbes AlexandriaPresident & CEOJan 28Sale17.3615,000260,3281,463,081Jan 30 05:30 PM
Giroux RichardCFO & COOJan 22Sale19.349,000174,0601,167,868Jan 23 04:42 PM
Giroux RichardCFO & COOJan 21Sale19.569,000175,9971,176,868Jan 23 04:42 PM
Seligman NicoleDirectorNov 19Buy16.315,00081,5505,000Nov 20 04:47 PM